Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Renaud Heine"'
Autor:
Renaud Heine, Frederick W. Thielen, Marc Koopmanschap, Marie José Kersten, Hermann Einsele, Ulrich Jaeger, Pieter Sonneveld, Jorge Sierra, Carin Smand, Carin A. Uyl-de Groot
Publikováno v:
HemaSphere, Vol 5, Iss 2, p e524 (2021)
Since 2018, 2 chimeric antigen receptor (CAR) T-cell therapies received approval from the European Medicine Agency, with list prices around 320 000 Euro (€) (EUR) per treatment. These high prices raise concerns for patient access and the sustainabi
Externí odkaz:
https://doaj.org/article/9f323ade3dc646c1a555182832fb1ee3
Autor:
Stefan Rabbe, Meilin Möllenkamp, Benedetta Pongiglione, Hedwig Blommestein, Pim Wetzelaer, Renaud Heine, Jonas Schreyögg
Publikováno v:
Health Economics (United Kingdom), 31(S1), 135-156. John Wiley & Sons Ltd.
Variation in healthcare utilization has been discussed extensively, with many studies showing that variation exists, but fewer studies investigating the underlying factors. In our study, we used a logistic multilevel-model at the patient, hospital, a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9b3043889631f4b93960a3d36694c628
https://doi.org/10.1002/hec.4492
https://doi.org/10.1002/hec.4492
Autor:
Peter Cram, Laura A Hatfield, Pieter Bakx, Amitava Banerjee, Christina Fu, Michal Gordon, Renaud Heine, Nicole Huang, Dennis Ko, Lisa M Lix, Victor Novack, Laura Pasea, Feng Qiu, Therese A Stukel, Carin Uyl de Groot, Lin Yan, Bruce Landon
Publikováno v:
The BMJ, 377:e069164. BMJ Publishing Group
ObjectivesTo compare treatment and outcomes for patients admitted to hospital with a primary diagnosis of ST elevation or non-ST elevation myocardial infarction (STEMI or NSTEMI) in six high income countries with very different healthcare delivery sy
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3be59430b3a2f1ce88e689c2fbf18f17
https://pubmed.ncbi.nlm.nih.gov/35537718
https://pubmed.ncbi.nlm.nih.gov/35537718
Publikováno v:
Cancers
Cancers, 12(8), 1-17. Multidisciplinary Digital Publishing Institute (MDPI)
Volume 12
Issue 8
Cancers, Vol 12, Iss 2313, p 2313 (2020)
Cancers, 12(8), 1-17. Multidisciplinary Digital Publishing Institute (MDPI)
Volume 12
Issue 8
Cancers, Vol 12, Iss 2313, p 2313 (2020)
Background. Many new cancer medicines have been developed that can improve patients&rsquo
outcomes. However, access to these agents comes later in Europe than in the United States (US). The aim of this study is to assess the access in Europe to
outcomes. However, access to these agents comes later in Europe than in the United States (US). The aim of this study is to assess the access in Europe to
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::84bb9bbcdaafe23ad95bf7e195a7dc0e
https://pubmed.ncbi.nlm.nih.gov/32824444
https://pubmed.ncbi.nlm.nih.gov/32824444